Biomedical Engineering Reference
In-Depth Information
bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993;
147:301-306.
24. Kemeny DM, Vyas B, Vukmanovic-Stejic M, Thomas MJ, Noble A, Loh LC,
O'Connor BJ. CD8
þ
T cell subsets and chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 1999; 160:S33-S37.
25. Di Stefano A, Turato G, Maestrelli P, Mapp CE, Ruggieri MO, Roggeri A,
Boschetto P, Fabbri LM, Saetta M. Airflow limitation in chronic bronchitis
is associated with T-lymphocyte and macrophage infiltration in the bronchial
mucosa. Am J Respir Crit Care Med 1996; 153:629-632.
26. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bron-
chial biopsies of subjects with chronic bronchitis: inverse relationship of CD8
þ
T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155:852-857.
27. Niewoehner DE, Kleinerman J, Reisst DB. Pathologic changes in the periph-
eral airways of young cigarette smokers. N Engl J Med 1974; 291:755-758.
28. Hunninghake BW, Crystal RG. Cigarette smoking and lung destruction: accu-
mulation of neutrophils in the lung. Am Rev Respir Dis 1983; 128:833-838.
29. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp
CE, Fabbri LM, Donner CF, Saetta M. Severity of airflow limitation is asso-
ciated with severity of airway inflammation in smokers. Am J Respir Crit Care
Med 1998; 158:1277-1285.
30. Hogg JC, Wright JL, Wiggs BR, Coxson HO, Opazo Saez A, Pare PD. Lung
structure and function in cigarette smokers. Thorax 1994; 49:473-478.
31. Wright GL, Lawson LM, Par´ PD, Wiggs BJ, Kennedy S, Hogg JC. Morphol-
ogy of peripheral airways in current smokers and ex smokers. Am Rev Respir
Dis 1983; 127:474-477.
32. Turato G, Di Stefano A, Maestrelli P, Mapp Ce, Ruggieri MP, Roggeri A,
Fabbri LM, Saetta M. Effect of smoking cessation on airway inflammation
in chronic bronchitis. Am J Respir Crit Care Med 1995; 152:1262-1267.
33. Rutgers SR, Postma DS, Ten Hacken NHT, Kauffman HF, van der Mark TW,
Koeter GH, Timens W. Ongoing inflammation in patients with COPD who do
not currently smoke. Thorax 2000; 55:12-18.
34. Shapiro S. End stage chronic obstructive pulmonary disease: the cigarette is
burned out but the inflammation rages on. Am J Respir Crit Care Med 2001;
164:339-340.
35. Retamales I, Elliott M, Meshi B, Coxson HO, Pare P, Sciurba F, Rogers R,
Hayashi S, et al. Amplification of inflammation in emphysema and its associa-
tion with latent adenoviral
infection. Am J Respir Crit Care Med 2001;
164:469-473.
36. Hogg JC, Chu F, Utokparch S, et al. The nature of small airway obstruction in
chronic obstructive lung disease. N Engl J Med 2004; 350:2645-2653.
37. Dunnill MS. Pulmonary pathology. Emphysema. Chapter 6. Churchill:
Livingston 1982, 81-112.
38. Matsuba K, Thurlbeck WM. The number and dimensions of small airways in
emphysematous lungs. Am J Pathol 1972; 67:265-275.
39. Cosio M, Ghezzo M, Hogg JC, et al. The relation between structural changes in
small airways and pulmonary function tests. New Eng J Med 1978; 298:
1277-1281.
